|
MED10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.251440E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.199400E-01 |
| Normal-vs-Stage2 |
2.724800E-01 |
| Normal-vs-Stage3 |
3.227900E-02 |
| Normal-vs-Stage4 |
1.249890E-02 |
| Stage1-vs-Stage2 |
3.449200E-01 |
| Stage1-vs-Stage3 |
4.819700E-02 |
| Stage1-vs-Stage4 |
7.479700E-02 |
| Stage2-vs-Stage3 |
3.222000E-01 |
| Stage2-vs-Stage4 |
3.926400E-01 |
| Stage3-vs-Stage4 |
9.008400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.089600E-01 |
| Normal-vs-AfricanAmerican |
2.642400E-01 |
| Normal-vs-Asian |
3.959100E-04 |
| Caucasian-vs-AfricanAmerican |
8.762800E-01 |
| Caucasian-vs-Asian |
4.266400E-02 |
| AfricanAmerican-vs-Asian |
4.284300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.898400E-01 |
| Normal-vs-Female |
9.438700E-03 |
| Male-vs-Female |
1.716250E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.055780E-01 |
| Normal-vs-Extreme_Weight |
4.003000E-01 |
| Normal-vs-Obese |
4.668400E-01 |
| Normal-vs-Extreme_Obese |
1.552030E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.298000E-01 |
| Normal_Weight-vs-Obese |
3.743000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.288400E-02 |
| Extreme_Weight-vs-Obese |
9.915000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.758840E-01 |
| Obese-vs-Extreme_Obese |
2.145600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.487670E-02 |
| Normal-vs-Age(41-60Yrs) |
5.253800E-02 |
| Normal-vs-Age(61-80Yrs) |
8.789800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.298000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.560400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.739900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.433000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.330400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.542200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.211800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.741400E-01 |
| Normal-VS-Type2 PRCC |
4.249800E-01 |
| Normal-VS-KIRP CIMP |
1.215420E-01 |
| Normal-VS-Unclassified PRCC |
2.108200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.635400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.021900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.075800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.424170E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.867400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.903200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.273400E-01 |
| Normal-vs-N1 |
6.978400E-03 |
| Normal-vs-N2 |
8.863600E-01 |
| N0-vs-N1 |
2.234000E-02 |
| N0-vs-N2 |
9.500400E-01 |
| N1-vs-N2 |
3.051200E-01 |
|
|
